Impellam Group plc (IGPPF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Impellam Group plc (IGPPF) with AI Score 41/100 (Weak). Impellam Group plc is a global staffing and human capital management firm operating in the UK, North America, Europe, and Australasia. Market cap: 0, Sector: Industrials.
Last analyzed: Mar 17, 2026Impellam Group plc (IGPPF) Industrial Operations Profile
Impellam Group plc offers comprehensive staffing and human capital management solutions across diverse sectors, including STEM, healthcare, and managed services, with a global presence spanning the UK, North America, Europe, and Australasia, positioning it as a key player in the international staffing market.
Investment Thesis
Impellam Group plc presents a mixed investment case. The company's diverse service offerings across multiple sectors and geographies provide a degree of resilience. The dividend yield of 8.96% may attract income-focused investors. However, the relatively high P/E ratio of 47.03 and a low profit margin of 0.4% raise concerns about valuation and profitability. Future growth will depend on the company's ability to capitalize on the increasing demand for specialized staffing solutions, particularly in the STEM and healthcare sectors. Investors should monitor the company's ability to improve profitability and manage its debt levels. The beta of 0.41 suggests lower volatility compared to the market.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.50 billion indicates a mid-sized player in the staffing industry.
- P/E ratio of 47.03 suggests a potentially high valuation compared to earnings.
- Dividend yield of 8.96% offers a substantial income stream for investors.
- Gross margin of 10.5% reflects the company's profitability after accounting for the cost of goods sold.
- Beta of 0.41 indicates lower volatility compared to the overall market.
Competitors & Peers
Strengths
- Diversified service offerings across multiple sectors.
- Global presence in key geographic markets.
- Specialized expertise in STEM and healthcare recruitment.
- Established brands with strong reputations.
Weaknesses
- Relatively low profit margin.
- High P/E ratio.
- Dependence on economic conditions.
- Exposure to regulatory changes in different countries.
Catalysts
- Ongoing: Increasing demand for specialized staffing solutions in the STEM sector.
- Ongoing: Growing need for healthcare workforce solutions.
- Ongoing: Adoption of managed services in talent acquisition.
- Upcoming: Potential expansion into new geographic markets.
- Ongoing: Leveraging digital technologies to enhance recruitment processes.
Risks
- Potential: Economic downturns affecting demand for staffing services.
- Potential: Regulatory changes impacting labor laws.
- Potential: Technological disruptions in recruitment processes.
- Ongoing: Intense competition in the staffing industry.
- Ongoing: Relatively low profit margin.
Growth Opportunities
- Expansion in the STEM Sector: The increasing demand for science, technology, engineering, and mathematics professionals presents a significant growth opportunity for Impellam Group plc. The STEM sector is experiencing rapid growth, driven by technological advancements and the need for specialized skills. Impellam Group, through its Lorien, Carbon60, Bartech, and SRG brands, can capitalize on this trend by expanding its recruitment services in this sector. The global STEM workforce is projected to grow substantially, creating a large addressable market for Impellam's specialized staffing solutions. Timeline: Ongoing.
- Healthcare Workforce Solutions: The healthcare industry faces a growing shortage of medical professionals, creating a strong demand for healthcare workforce solutions. Impellam Group plc, through its Medacs Healthcare, Global Medics, and Litmus Workforce Solutions brands, is well-positioned to capitalize on this trend. The increasing demand for nurses, doctors, and allied health professionals presents a significant growth opportunity for the company. The global healthcare staffing market is expected to continue growing, driven by aging populations and increasing healthcare needs. Timeline: Ongoing.
- Growth in Managed Services: The increasing adoption of managed services in talent acquisition presents a significant growth opportunity for Impellam Group plc. Companies are increasingly outsourcing their recruitment processes to managed service providers to improve efficiency and reduce costs. Impellam Group, through its Comensura, Guidant Global, and Flexy brands, can capitalize on this trend by expanding its managed service offerings. The global managed services market is expected to continue growing, driven by the increasing need for talent acquisition solutions. Timeline: Ongoing.
- Geographic Expansion: Expanding into new geographic markets presents a significant growth opportunity for Impellam Group plc. The company currently operates in the United Kingdom, North America, Europe, and Australasia. Expanding into new regions, such as Asia and South America, can provide access to new talent pools and client bases. The global staffing market is diverse, with significant growth potential in emerging markets. Timeline: Medium-term.
- Digital Transformation: Leveraging digital technologies to enhance recruitment processes presents a significant growth opportunity for Impellam Group plc. The adoption of artificial intelligence, machine learning, and data analytics can improve the efficiency and effectiveness of recruitment services. Impellam Group can invest in digital platforms and tools to enhance its candidate sourcing, screening, and matching capabilities. The use of digital technologies can also improve the candidate and client experience. Timeline: Ongoing.
Opportunities
- Expansion in the STEM sector.
- Growth in healthcare workforce solutions.
- Increasing adoption of managed services.
- Geographic expansion into new markets.
Threats
- Intense competition in the staffing industry.
- Economic downturns affecting demand for staffing services.
- Regulatory changes impacting labor laws.
- Technological disruptions in recruitment processes.
Competitive Advantages
- Diversified service offerings across multiple sectors.
- Global presence in key geographic markets.
- Specialized expertise in STEM and healthcare recruitment.
- Established brands with strong reputations.
About IGPPF
Impellam Group plc, established in 2008 and headquartered in Luton, UK, provides a wide array of staffing solutions, human capital management, and outsourced people-related services. The company operates across the United Kingdom, North America, Europe, and Australasia, catering to various industries through its four primary segments: Global Managed Services, STEM, Regional Specialist Staffing, and Healthcare. The Global Managed Services segment, operating under brands like Comensura, Guidant Global, and Flexy, focuses on designing and implementing talent acquisition processes through outsourced recruitment services. The STEM segment, which includes Lorien, Carbon60, Bartech, and SRG, specializes in the recruitment of scientists, clinicians, engineers, IT, and digital specialists on both contract and permanent bases. The Regional Specialist Staffing segment, with brands such as Blue Arrow, Tate, Career Teacher, and Chadwick Nott, provides staffing solutions for various roles, including warehouse workers, secretaries, lawyers, and teachers. The Healthcare segment, operating under Medacs Healthcare, Global Medics, and Litmus Workforce Solutions, offers healthcare workforce solutions, including staffing, managed services, and recruitment of medical professionals. Impellam Group's diverse service offerings and global presence enable it to serve a broad range of client needs in the evolving staffing and human capital management landscape.
What They Do
- Provides global managed services for talent acquisition.
- Offers specialist contract and permanent recruitment services in STEM fields.
- Provides staffing solutions for various roles, including warehouse workers and administrative staff.
- Offers healthcare workforce solutions, including staffing and managed services.
- Recruits locum, temporary, and permanent doctors, nurses, and care workers.
- Provides human capital management services.
- Offers outsourced people-related services.
Business Model
- Generates revenue through fees for staffing and recruitment services.
- Earns revenue from managed service contracts with clients.
- Provides workforce solutions on a contract and permanent basis.
- Offers specialized recruitment services in high-demand sectors.
Industry Context
Impellam Group plc operates in the global staffing and employment services industry, which is characterized by increasing demand for flexible workforce solutions and specialized skills. The industry is influenced by factors such as economic growth, technological advancements, and demographic shifts. Key competitors include companies like Adecco (AYAG), offering similar staffing and recruitment services. Impellam Group's focus on specialized sectors like STEM and healthcare positions it to capitalize on the growing demand for talent in these areas. The industry is expected to continue growing, driven by the increasing need for workforce flexibility and specialized skills.
Key Customers
- Companies in various industries seeking staffing solutions.
- Organizations in the STEM sector requiring specialized talent.
- Healthcare providers needing workforce solutions.
- Businesses outsourcing their talent acquisition processes.
Financials
Chart & Info
Impellam Group plc (IGPPF) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Lows On Friday
· Oct 4, 2019
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IGPPF.
Price Targets
Wall Street price target analysis for IGPPF.
MoonshotScore
What does this score mean?
The MoonshotScore rates IGPPF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Staffing & Employment ServicesLeadership: Julia Robertson
CEO
Julia Robertson serves as the CEO of Impellam Group plc. Her career spans various leadership roles within the staffing and recruitment industry. She has extensive experience in driving business growth, developing strategic partnerships, and managing large teams. Her expertise lies in developing and implementing innovative workforce solutions to meet the evolving needs of clients. She is known for her focus on creating a positive and inclusive work environment.
Track Record: Under Julia Robertson's leadership, Impellam Group plc has expanded its global presence and diversified its service offerings. She has overseen the acquisition and integration of several key businesses, strengthening the company's position in the staffing and human capital management market. She has also focused on driving digital transformation initiatives to enhance the company's recruitment processes.
IGPPF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Impellam Group plc may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial information available, and the trading of their shares can be more speculative compared to companies listed on major exchanges like the NYSE or NASDAQ. Investors should exercise caution and conduct thorough due diligence before investing in companies on the OTC Other tier.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Lower trading volume and liquidity.
- Potential for price volatility.
- Higher risk of fraud or manipulation.
- Limited regulatory oversight.
- Verify the company's financial statements.
- Research the company's management team.
- Assess the company's business model and competitive landscape.
- Review the company's legal and regulatory filings.
- Evaluate the company's risk factors.
- Check for any red flags or warning signs.
- Consult with a financial advisor.
- Established operating history.
- Presence in multiple geographic markets.
- Diversified service offerings.
- Experienced management team.
- Positive customer reviews.
IGPPF Industrials Stock FAQ
What does Impellam Group plc do?
Impellam Group plc is a global provider of staffing solutions, human capital management, and outsourced people-related services. The company operates through four segments: Global Managed Services, STEM, Regional Specialist Staffing, and Healthcare. It offers a range of services, including recruitment, talent acquisition, and workforce management, catering to various industries and sectors. Impellam Group's business model focuses on providing flexible and specialized workforce solutions to meet the evolving needs of its clients, generating revenue through fees for staffing and recruitment services.
What do analysts say about IGPPF stock?
AI analysis is pending for IGPPF. As of March 17, 2026, there is no available analyst consensus on Impellam Group plc (IGPPF). Investors should conduct their own due diligence and consider the company's financial performance, growth prospects, and risk factors before making any investment decisions. Key valuation metrics to consider include the P/E ratio, dividend yield, and profit margin. Growth considerations include the company's ability to capitalize on the increasing demand for specialized staffing solutions and expand into new markets.
What are the main risks for IGPPF?
Impellam Group plc faces several risks, including economic downturns affecting demand for staffing services, regulatory changes impacting labor laws, and technological disruptions in recruitment processes. Intense competition in the staffing industry and the company's relatively low profit margin also pose challenges. Additionally, as an OTC stock, IGPPF is subject to risks associated with limited financial disclosure, lower trading volume, and potential price volatility. Investors should carefully consider these risks before investing in IGPPF.
What are the key factors to evaluate for IGPPF?
Impellam Group plc (IGPPF) currently holds an AI score of 41/100, indicating low score. Key strength: Diversified service offerings across multiple sectors.. Primary risk to monitor: Potential: Economic downturns affecting demand for staffing services.. This is not financial advice.
How frequently does IGPPF data refresh on this page?
IGPPF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven IGPPF's recent stock price performance?
Recent price movement in Impellam Group plc (IGPPF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified service offerings across multiple sectors.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider IGPPF overvalued or undervalued right now?
Determining whether Impellam Group plc (IGPPF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying IGPPF?
Before investing in Impellam Group plc (IGPPF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.
- AI analysis pending.